In this interview, Dr. Peng Ling from the First Affiliated Hospital,School of Medicine, Zhejiang University, Dr. Mei Heng from the Union Hospital, Tongji M..
作者:肿瘤瞭望 有17012人浏览 发布于:2020-06-23
In this interview, Professor Xu Yingying from the First Affiliated Hospital of China Medical University will talk with Professor Javier Cortes from IOB, Insti..
作者:肿瘤瞭望 有16399人浏览 发布于:2020-06-23
Editor’s note: The annual meeting of American Society of Clinical Oncology (ASCO) was held in the form of online conference for the first time, the theme of ..
作者:肿瘤瞭望 有24186人浏览 发布于:2020-06-23
At the 2020 ASCO conference, Professor Thomas Powles from Barts Cancer Institute and the London School of Medicine and Dentistry, UK, has reported the JAVELI..
作者:肿瘤瞭望 有13982人浏览 发布于:2020-06-23
Editor’s note: May 29th, 2020 to 2nd June 2020, the annual meeting of the American Society of Clinical Oncology (ASCO) was held as a virtual meeting online ..
作者:肿瘤瞭望 有26883人浏览 发布于:2020-06-23
The Annual Meeting of American Society of Clinical Oncology (ASCO) this year was held on-line during 29/5 to 2/6. In the meeting, the Long-term result of trial..
作者:肿瘤瞭望 有13656人浏览 发布于:2020-06-23
编者按:2020年ASCO年会已在线上成功举办,在这场国际肿瘤学的奥斯卡盛典上,乳腺癌领域唯一一项入选LBA(Late-Breaking Abstract)的 ECOG-ACRIN 2108研究引起了专家学者..
作者:肿瘤瞭望 有13438人浏览 发布于:2020-06-23
2020年6月11日,来自全国各地的9位乳腺癌大咖再次齐聚“恒聚e堂”,共同参加由 中国医学科学院肿瘤医院徐兵河教授主持的“2020 ASCO乳腺癌研究进展”专场,邀 请了江苏省人..
作者:肿瘤瞭望 有49097人浏览 发布于:2020-06-23
编者按:美国临床肿瘤学会(ASCO)年会已经落下帷幕,虽然受新冠疫情影响,ASCO首次以线上会议形式召开,但精彩程度及重磅研究可谓毫不逊色。外周T细胞淋巴瘤(PTCL)一直..
作者:肿瘤瞭望 有19341人浏览 发布于:2020-06-23
雌激素受体阳性(ER+)乳腺癌是最常见的乳腺癌亚型。ER+乳腺癌的治疗中非常重要的一部分就是内分泌治疗,尽管内分泌疗法已大大降低了乳腺癌的复发率和死亡率,但原发性耐药..
作者:肿瘤瞭望 有21565人浏览 发布于:2020-06-22
ESMO 2025丨三种新型策略有望助力破解..
ASH 2025丨血液时讯六大栏目带您开启AS..
臧荣余教授谈亚洲视角下PDS与NACT-IDS..
邓婷教授介绍卵巢癌LOVE研究进展,解读..